Time to read
2 minutes
Read so far

Losing 13% of body weight demonstrates benefits for metabolic conditions

Mon, 09/07/2020 - 16:03
Posted in:

Observational study shows that there is an association between weight loss and reduced cardiovascular risk factors, not that weight loss causes that reduction in risk

People with obesity who intentionally (not because of illness) lost an average (median) 13% of their initial body weight reduced their relative risk of developing type 2 diabetes by 42%-44%, sleep apnoea by 22%-27%, high blood pressure by 18%-25%, and dyslipidaemia by 20-22%, according to a study of over 550,000 adults in primary care in the UK. The study authors believe it is the first of its kind to quantify the benefits of intentional weight loss on the risk of obesity-related conditions in real-world clinical practice. The research was presented at The European and International Congress on Obesity.

In the study, researchers analysed anonymised data from the UK Clinical Practice Research Datalink (CPRD) database, which holds information on over 11 million patients from 674 general practice surgeries in the UK, dating from 1987 to the present and Hospital Episodes Statistics. They extracted data on over 550,000 adults (average age 51 years) with overweight or obesity between January 2001 and December 2010.

Participants were divided into two groups based on their weight pattern during a four-year period after the first BMI measurement was taken - 492,380 individuals whose weight remained stable (margin allowed for BMI change -5% to +5%) and 60,573 who lost weight (requiring BMI change -10% to -25%). Average (median) BMI change in the weight-loss group was -13%. They also extracted information on weight loss interventions and dietary advice to confirm intention to lose weight.

The researchers compared the risk of developing six obesity-related conditions (type 2 diabetes, sleep apnoea, osteoarthritis, hypertension, dyslipidaemia, and unstable angina/heart attack) among those who lost weight and those who did not, during an average of eight years follow up.

They then calculated the benefits of losing 13% of body weight for three risk profiles BMI reduction from 34.5 to 30; 40.3 to 35 and from 46 to 40. The results were adjusted for factors that could affect the findings including age, sex, smoking, and existing comorbidities (eg, type 2 diabetes, high blood pressure, abnormal blood fats, history of cardiovascular events).

Overall, the largest risk reductions were noted for type 2 diabetes. The estimates suggest that 13% weight loss in adults with obesity from BMI 34.5 to 30.0 was associated with a 42% reduction in the relative risk of developing type 2 diabetes, a 25% reduction in the relative risk of developing high blood pressure and sleep apnoea and a 20-22% reduction in osteoarthritis and dyslipidaemia risk, compared to risks before weight loss. The trends for individuals who reduced their BMI from 40.3 to 35 and 46 to 40 were similar. However, the reduction in unstable angina/heart attack risk was not significant.

Further analyses looking at whether people with an average 13% weight loss were at the same risk of obesity-related conditions as if they been at this 13% lower weight from the start of the study, found that those who lost weight were at significantly lower risk of developing type 2 diabetes, high blood pressure,and abnormal blood fats. However, at each of the three risk profiles, the risk of developing sleep apnoea and osteoarthritis after weight loss was still higher compared with having 13% lower stable weight from the start of the study (so called 'residual risk').

The findings are likely to be generalisable to the whole of the UK and most Western countries because of the diverse nature of the UK population within the CPRD database. However, the authors acknowledge several limitations, including that patients must have been to their doctor and had their BMI measured for a reason, and that other factors that could affect the results may be unknown or unmeasurable.

"Our results demonstrate the benefits of intentional weight loss in reducing the health burdens of obesity in real-world clinical practice," explained Christiane L Haase from Novo Nordisk, Denmark, who led the research. "It is important to emphasise that this is an observational study and can only show that there is an association between weight loss and reduced cardiovascular risk factors, not that weight loss causes that reduction in risk. Nevertheless, the difference in the risk of these conditions is striking and indicates that people with obesity could markedly reduce their disease risk through intentional weight loss. What we need to focus on now is how we can support healthy, evidence-based approaches to losing weight and how best to maintain any weight loss achieved."